ETON NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Eton Pharmaceuticals Inc · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data Download investor PDF
Latest close 42.59 USD
0.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 67.2% above the Trend Line and sits at 92.5% of its 52-week range. The latest completed week returned 0.6%, after a 19.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. Options positioning is volatility with 54/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: price is close to its 52-week high; earnings are due in 7d.

Setup score 76 out of 100
Latest Close 42.59 USD 24 Jul 2026
1W Return 0.6% latest completed week
4W Return 19.3% short-term follow-through
12W Return 47.4% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • The trend backdrop is active with a 17-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 10 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.6% Latest completed week; four-week move 19.3%. Indicator stack 77/82 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 57.15% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 54/100 conviction; expected move 20.5%. News sentiment 54/100 53 relevant articles in the latest sentiment read. Event risk 7d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 67.2% above the Trend Line and sits at 92.5% of its 52-week range. The latest completed week returned 0.6%, after a 19.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9212-week average 0.87

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.92Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1010 reversal markers

No recent accumulation markers. 10 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 19.3% over four weeks, 47.4% over 12 weeks, and 176.6% over one year. The current trend has remained active for 17 consecutive weeks.

Performance by holding period

1W0.6%
4W19.3%
12W47.4%
26W184.1%
52W176.6%
Active trend streak17 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.61Latest activity-pressure read.
Pressure change35.1%Four-week change in activity pressure.
Leadership79.97Latest relative-leadership reading.
RS change41.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 88% Model confidence 84%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength39/100Blend of value, momentum, and quality. Underlying universe rank 62; rank 1 is best.
Value3/100Relative valuation strength. Underlying universe rank 98; rank 1 is best.
Quality75/100Profitability and accounting quality. Underlying universe rank 26; rank 1 is best.
Momentum97/100Medium-term price momentum. Underlying universe rank 4; rank 1 is best.
Growth88/100Revenue and earnings growth. Underlying universe rank 13; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
13.4x
Market value relative to trailing revenue.
EV / EBITDA
212.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
54.8%
Gross profit retained from each unit of revenue.
Operating margin
1.5%
Operating profit retained from revenue.
Free-cash-flow margin
18.7%
Free cash flow generated from revenue.
Return on invested capital
4.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
79.9%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
119.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.2%
Net share repurchases relative to market value.
Shareholder yield
-0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

ETON shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 0.68, expected move of 20.5%, and Sharemaestro trend signal active.

Conviction54/100
Expected move20.5%
Put/call volume0.68
Pressure21
Speculation53
Volatility89
Trend agreement95
Open options detail
Insider activity6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 53 relevant articles.

20 positive · 25 neutral · 8 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings7dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move20.5%Nearest-chain priced movement where available.
52-week drawdown-5.2%Distance below the 52-week high.
13-week volatility8.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher18 of 268 weeks finished lower.
Best week+25.5%Week of 1 May.
Worst week-8.1%Week of 24 Apr.
Latest week+0.6%Week of 24 Jul.

Shape of recent returns

Strong gains13
Modest gains5
Flat weeks0
Modest losses3
Sharp losses5
Recent vol8.3%13-week weekly-return volatility.
Base vol7.6%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew7.0% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape74/100

Trend, activity pressure, participation, and risk combine to a 74/100 tape read.

 Indicator analysis82/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.92; 10 reversal markers Next-Week ExpectancyPositive 57.15%

Next-week expectancy is positive with a 57.15% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors52/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 73; Small Cap Core rank 99 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options63/100

ETON shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 0.68, expected move of 20.5%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 20.5% Sentiment54/100

Weighted news tone is neutral across 53 relevant articles.

Eton Pharmaceuticals Inc (ETON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution Insiders6 / 14

6 acquisitions and 14 disposals in the latest 180-day insider tape.

 Earnings7d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202642.59 USD0.6%25.47 USD12.76 USD1.6179.972.9MOn
17 Jul 202642.32 USD15.6%24.61 USD12.51 USD1.5779.463.1MOn
10 Jul 202636.61 USD-2.4%23.75 USD12.26 USD1.4251.721.8MOn
3 Jul 202637.50 USD5.0%23.08 USD12.04 USD1.3460.472.1MOn
26 Jun 202635.70 USD9.9%22.37 USD11.82 USD1.1956.512.7MOn
19 Jun 202632.48 USD2.8%21.72 USD11.61 USD1.0238.041.4MOn
12 Jun 202631.59 USD8.4%21.19 USD11.43 USD1.1839.361.5MOn
5 Jun 202629.13 USD-4.3%20.70 USD11.25 USD1.3032.822.1MOn
29 May 202630.45 USD-6.6%20.29 USD11.09 USD1.5033.361.6MOn
22 May 202632.59 USD7.7%19.88 USD10.92 USD1.6247.302.5MOn
15 May 202630.26 USD2.1%19.41 USD10.74 USD1.3638.981.7MOn
8 May 202629.65 USD2.6%19.00 USD10.57 USD1.3536.272.6MOn
1 May 202628.90 USD25.5%18.67 USD10.40 USD1.3040.771.8MOn
24 Apr 202623.02 USD-8.1%18.37 USD10.24 USD1.3714.391.4MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.